Home LiteratureArticle Details
PMID: 11474495 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis.

International journal of cancer ·Vol. 96 ·No. 4 ·2001-08-20 ·Pages 213-20

Sheard MA

Abstract

CD95 (Fas/APO-1) is a death receptor on the surface of a wide variety of cell types. In most cells examined, ionizing radiation acts as a response-enhancing agent for CD95-mediated cell death. Although DNA-damaging radiation appears to modulate CD95-mediated signals through multiple mechanisms, the only well-characterized mechanism is activation of the tumor-suppressor protein p53, which transcriptionally regulates the expression of CD95 on various cell types. The ligand for CD95 is expressed by activated lymphocytes and natural-killer cells, which produce factors that sensitize cells resistant to CD95-mediated cell death. Ligation of CD95 on irradiated tumor cells might be achievable using emerging modalities that reactivate the stalled anti-tumor immune response.

MeSH Terms
Animals Apoptosis Humans Killer Cells, Natural/metabolism,radiation effects Ligands Lymphocytes/metabolism,radiation effects Models, Biological Neoplasms/drug therapy,radiotherapy Radiation, Ionizing Signal Transduction/radiation effects Transcription, Genetic fas Receptor/metabolism
Chemicals
Ligands fas Receptor
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Sheard M A
Department of Cellular and Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. sheard@mou.cz
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
2001-08-20
Pages
213-20
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com